Clinical Trials · NCT01458301
Efficacy and Safety of TAK-385 in the Treatment of Endometriosis
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Takeda
- Enrollment
- 487
- Start date
- Oct 2011
- Locations
- 69 sites, Japan
- Primary endpoint
- Score for pelvic pain as measured by the Visual Analogue Scale (VAS)